Works matching AU Alten, Rieke

Results: 88

Subcutaneous abatacept for the treatment of rheumatoid arthritis in routine clinical practice in Germany, Austria, and Switzerland: 2-year retention and efficacy by treatment line and serostatus.

Published in:

Clinical Rheumatology, 2023, v. 42, n. 9, p. 2321, doi. 10.1007/s10067-023-06649-x

By:

Alten, Rieke;
Tony, Hans-Peter;
Bannert, Bettina;
Nüßlein, Hubert;
Rauch, Christiane;
Connolly, Sean E.;
Chartier, Melanie;
Lozenski, Karissa;
Hackl, Roland;
Forster, Adrian;
Peichl, Peter

Publication type:

Article

Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study.

Published in:

Clinical Rheumatology, 2022, v. 41, n. 8, p. 2361, doi. 10.1007/s10067-022-06176-1

By:

Alten, Rieke;
Mariette, Xavier;
Flipo, René-Marc;
Caporali, Roberto;
Buch, Maya H.;
Patel, Yusuf;
Marsal, Sara;
Sanmartí, Raimon;
Nurmohamed, Michael T.;
Griffiths, Hedley;
Peichl, Peter;
Bannert, Bettina;
Chartier, Melanie;
Connolly, Sean E.;
Lozenski, Karissa;
Rauch, Christiane

Publication type:

Article

Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries.

Published in:

Clinical Rheumatology, 2019, v. 38, n. 11, p. 3049, doi. 10.1007/s10067-019-04648-5

By:

Alten, Rieke;
Feist, Eugen;
Lorenz, Hanns-Martin;
Nüßlein, Hubert;
Voll, Reinhard E.;
Chartier, Melanie;
Elbez, Yedid;
Rauch, Christiane

Publication type:

Article

Unmet needs in psoriatic arthritis patients receiving immunomodulatory therapy: results from a large multinational real-world study.

Published in:

Clinical Rheumatology, 2019, v. 38, n. 6, p. 1615, doi. 10.1007/s10067-019-04446-z

By:

Alten, Rieke;
Conaghan, P. G.;
Strand, V.;
Sullivan, E.;
Blackburn, S.;
Tian, H.;
Gandhi, K.;
Jugl, S. M.;
Deodhar, A.

Publication type:

Article

Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.

Published in:

2019

By:

Alten, Rieke;
Mariette, Xavier;
Lorenz, Hanns-Martin;
Nüßlein, Hubert;
Galeazzi, Mauro;
Navarro, Federico;
Chartier, Melanie;
Heitzmann, Julia;
Poncet, Coralie;
Rauch, Christiane;
Le Bars, Manuela

Publication type:

Correction Notice

Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.

Published in:

Clinical Rheumatology, 2019, v. 38, n. 5, p. 1413, doi. 10.1007/s10067-019-04449-w

By:

Alten, Rieke;
Mariette, Xavier;
Lorenz, Hanns-Martin;
Nüßlein, Hubert;
Galeazzi, Mauro;
Navarro, Federico;
Chartier, Melanie;
Heitzmann, Julia;
Poncet, Coralie;
Rauch, Christiane;
Le Bars, Manuela

Publication type:

Article

Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis.

Published in:

Clinical Rheumatology, 2017, v. 36, n. 12, p. 2655, doi. 10.1007/s10067-017-3788-1

By:

D'Agostino, Maria-Antonietta;
Alten, Rieke;
Mysler, Eduardo;
Bars, Manuela;
Ye, June;
Murthy, Bindu;
Heitzmann, Julia;
Vadanici, Radu;
Ferraccioli, Gianfranco

Publication type:

Article

A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4527, doi. 10.3390/jcm12134527

By:

Taylor, Peter C.;
Laedermann, Cedric;
Alten, Rieke;
Feist, Eugen;
Choy, Ernest;
Haladyj, Ewa;
De La Torre, Inmaculada;
Richette, Pascal;
Finckh, Axel;
Tanaka, Yoshiya

Publication type:

Article

Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA).

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 24, p. 7316, doi. 10.3390/jcm11247316

By:

Koehm, Michaela;
Foldenauer, Ann C.;
Rossmanith, Tanja;
Alten, Rieke;
Aringer, Martin;
Backhaus, Marina;
Burmester, Gerd R.;
Feist, Eugen;
Kellner, Herbert;
Krueger, Klaus;
Müller-Ladner, Ulf;
Rubbert-Roth, Andrea;
Tony, Hans-Peter;
Wassenberg, Siegfried;
Burkhardt, Harald;
Behrens, Frank

Publication type:

Article

Eosinophilic fasciitis (Shulman syndrome)—recognition of the histological spectrum allows for new insights into possible pathomechanisms.

Published in:

Rheumatology, 2023, v. 62, n. 5, p. 2005, doi. 10.1093/rheumatology/keac526

By:

Pehl, Debora;
Preuße, Corinna;
Allenbach, Yves;
Benveniste, Olivier;
Dittert, Philipp;
Alten, Rieke;
Krause, Andreas;
Görl, Norman;
Zänker, Michael;
Goebel, Hans-Hilmar;
Schneider, Udo;
Stenzel, Werner

Publication type:

Article

Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study).

Published in:

Rheumatology, 2021, v. 60, n. 11, p. 5318, doi. 10.1093/rheumatology/keab153

By:

Behrens, Frank;
Koehm, Michaela;
Rossmanith, Tanja;
Alten, Rieke;
Aringer, Martin;
Backhaus, Marina;
Burmester, Gerd R;
Feist, Eugen;
Herrmann, Eva;
Kellner, Herbert;
Krueger, Klaus;
Lehn, Annette;
Müller-Ladner, Ulf;
Rubbert-Roth, Andrea;
Tony, Hans-Peter;
Wassenberg, Siegfried;
Burkhardt, Harald

Publication type:

Article

Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6month phase 3 clinical trial and extension study.

Published in:

Rheumatology, 2017, v. 56, n. 12, p. 2170, doi. 10.1093/rheumatology/kex350

By:

Tausche, Anne-Kathrin;
Alten, Rieke;
Dalbeth, Nicola;
Kopicko, Jeff;
Fung, Maple;
Adler, Scott;
Bhakta, Nihar;
Storgard, Chris;
Baumgartner, Scott;
Saag, Kenneth

Publication type:

Article

The Adherence and Outcomes Benefits of Using a Connected, Reusable Auto-Injector for Self-Injecting Biologics: A Narrative Review.

Published in:

Advances in Therapy, 2023, v. 40, n. 11, p. 4758, doi. 10.1007/s12325-023-02671-2

By:

Antalfy, Attila;
Berman, Kyle;
Everitt, Claire;
Alten, Rieke;
Latymer, Mark;
Godfrey, Charles M.

Publication type:

Article

Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.

Published in:

Advances in Therapy, 2023, v. 40, n. 4, p. 1867, doi. 10.1007/s12325-023-02445-w

By:

Taylor, Peter C.;
Bieber, Thomas;
Alten, Rieke;
Witte, Torsten;
Galloway, James;
Deberdt, Walter;
Issa, Maher;
Haladyj, Ewa;
De La Torre, Inmaculada;
Grond, Susanne;
Wollenberg, Andreas

Publication type:

Article

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era.

Published in:

Advances in Therapy, 2022, v. 39, n. 6, p. 2342, doi. 10.1007/s12325-021-01990-6

By:

Schreiber, Stefan;
Ben-Horin, Shomron;
Alten, Rieke;
Westhovens, René;
Peyrin-Biroulet, Laurent;
Danese, Silvio;
Hibi, Toshifumi;
Takeuchi, Ken;
Magro, Fernando;
An, Yoorim;
Kim, Dong-Hyeon;
Yoon, SangWook;
Reinisch, Walter

Publication type:

Article

Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era.

Published in:

2022

By:

Schreiber, Stefan;
Ben-Horin, Shomron;
Alten, Rieke;
Westhovens, René;
Peyrin-Biroulet, Laurent;
Danese, Silvio;
Hibi, Toshifumi;
Takeuchi, Ken;
Magro, Fernando;
An, Yoorim;
Kim, Dong-Hyeon;
Yoon, SangWook;
Reinisch, Walter

Publication type:

corrected article

Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis.

Published in:

2019

By:

Gulácsi, László;
Zrubka, Zsombor;
Brodszky, Valentin;
Rencz, Fanni;
Alten, Rieke;
Szekanecz, Zoltán;
Péntek, Márta

Publication type:

journal article

So behandeln wir Rheumaknoten bei Patienten mit rheumatoider Arthritis in Remission.

Published in:

Zeitschrift für Rheumatologie, 2022, v. 81, n. 7, p. 605, doi. 10.1007/s00393-022-01228-y

By:

Mischkewitz, Max;
Alten, Rieke

Publication type:

Article

Improvement Thresholds for Morning Stiffness Duration in Patients Receiving Delayed- Versus Immediate-Release Prednisone for Rheumatoid Arthritis.

Published in:

Bulletin of the Hospital for Joint Diseases, 2015, v. 73, n. 3, p. 168

By:

Buttgereit, Frank;
Kent, Jeffrey D.;
Holt, Robert J.;
Grahn, Amy Y.;
Rice, Patricia;
Alten, Rieke;
Yazici, Yusuf

Publication type:

Article

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.

Published in:

Drugs, 2020, v. 80, n. 2, p. 99, doi. 10.1007/s40265-020-01256-5

By:

Kim, HoUng;
Alten, Rieke;
Avedano, Luisa;
Dignass, Axel;
Gomollón, Fernando;
Greveson, Kay;
Halfvarson, Jonas;
Irving, Peter M.;
Jahnsen, Jørgen;
Lakatos, Péter L.;
Lee, JongHyuk;
Makri, Souzi;
Parker, Ben;
Peyrin-Biroulet, Laurent;
Schreiber, Stefan;
Simoens, Steven;
Westhovens, Rene;
Danese, Silvio;
Jeong, Ji Hoon

Publication type:

Article

A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis.

Published in:

Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1676-y

By:

Fleischmann, Roy M.;
Alten, Rieke;
Pileckyte, Margarita;
Lobello, Kasia;
Hua, Steven Y.;
Cronenberger, Carol;
Alvarez, Daniel;
Bock, Amy E.;
Sewell, K. Lea

Publication type:

Article

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy.

Published in:

Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1646-4

By:

Cohen, Stanley B.;
Alten, Rieke;
Kameda, Hideto;
Hala, Tomas;
Radominski, Sebastiao C.;
Rehman, Muhammad I.;
Palaparthy, Ramesh;
Schumacher, Karl;
Schmitt, Susanne;
Hua, Steven Y.;
Ianos, Claudia;
Lea Sewell, K.

Publication type:

Article

Abatacept used in combination with nonmethotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting.

Published in:

Arthritis Research & Therapy, 2018, v. 20, n. 1, p. 1, doi. 10.1186/s13075-017-1488-5

By:

Alten, Rieke;
Burkhardt, Harald;
Feist, Eugen;
Krüger, Klaus;
Rech, Juergen;
Rubbert-Roth, Andrea;
Voll, Reinhard E.;
Elbez, Yedid;
Rauch, Christiane

Publication type:

Article

Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group.

Published in:

Journal of Rheumatology, 2017, v. 44, n. 12, p. 1904, doi. 10.3899/jrheum.161073

By:

Halls, Serena;
Sinnathurai, Premarani;
Hewlett, Sarah;
Mackie, Sarah L.;
March, Lyn;
Bartlett, Susan J.;
Bingham III, Clifton O.;
Alten, Rieke;
Campbell, Ina;
Hill, Catherine L.;
Holt, Robert J.;
Hughes, Rod;
Kirwan, John R.;
Leong, Amye L.;
Ying Ying Leung;
Lyddiatt, Anne;
Neill, Lorna;
Orbai, Ana-Maria

Publication type:

Article

An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.

Published in:

Journal of Rheumatology, 2017, v. 44, n. 11, p. 1734, doi. 10.3899/jrheum.161200

By:

Finger, Monika E.;
Boonen, Annelies;
Woodworth, Thasia G.;
Escorpizo, Reuben;
Christensen, Robin;
Nielsen, Sabrina M.;
Leong, Amye L.;
Voshaar, Marieke Scholte;
Flurey, Caroline A.;
Milman, Nataliya;
Verstappen, Suzanne M.;
Alten, Rieke;
Guillemin, Francis;
Kloppenburg, Margreet;
Beaton, Dorcas E.;
Tugwell, Peter S.;
March, Lyn M.;
Furst, Daniel E.;
Pohl, Christoph

Publication type:

Article

Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.

Published in:

2017

By:

Bartlett, Susan J.;
Barbic, Skye P.;
Bykerk, Vivian P.;
Choy, Ernest H.;
Alten, Rieke;
Christensen, Robin;
Broeder, Alfons den;
Fautrel, Bruno;
Furst, Daniel E.;
Guillemin, Francis;
Hewlett, Sarah;
Leong, Amye L.;
Lyddiatt, Anne;
March, Lyn;
Montie, Pamela;
Pohl, Christoph;
Voshaar, Marieke Scholte;
Woodworth, Thasia G.;
Bingham, Clifton O.;
den Broeder, Alfons

Publication type:

journal article

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.

Published in:

2016

By:

Alten, Rieke;
Bingham III, Clifton O.;
Cohen, Stanley B.;
Curtis, Jeffrey R.;
Kelly, Sheila;
Wong, Dennis;
Genovese, Mark C.;
Bingham, Clifton O 3rd

Publication type:

journal article

Febuxostat oder Allopurinol bei Patienten mit Gicht: Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES).

Published in:

Der Internist, 2020, v. 61, n. 5, p. 530, doi. 10.1007/s00108-020-00766-4

By:

Alten, R.;
Mischkewitz, M.;
Nitschmann, S.;
Alten, Rieke

Publication type:

Article

Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.

Published in:

Arthritis & Rheumatology, 2017, v. 69, n. 9, p. 1751, doi. 10.1002/art.40176

By:

Genovese, Mark C.;
Kremer, Joel M.;
van Vollenhoven, Ronald F.;
Alten, Rieke;
Scali, Juan Jose;
Kelman, Ariella;
Dimonaco, Sophie;
Brockwell, Laura

Publication type:

Article

Long-Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment.

Published in:

Arthritis & Rheumatology, 2014, v. 66, n. 8, p. 1987, doi. 10.1002/art.38687

By:

Alten, Rieke;
Kaine, Jeffrey;
Keystone, Edward;
Nash, Peter;
Delaet, Ingrid;
Genovese, Mark C.

Publication type:

Article

Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.

Published in:

Acta Neuropathologica Communications, 2016, v. 4, p. 1, doi. 10.1186/s40478-016-0308-5

By:

Preuße, Corinna;
Allenbach, Yves;
Hoffmann, Olaf;
Goebel, Hans-Hilmar;
Pehl, Debora;
Radke, Josefine;
Doeser, Alexandra;
Schneider, Udo;
Alten, Rieke H. E.;
Kallinich, Tilmann;
Benveniste, Olivier;
von Moers, Arpad;
Schoser, Benedikt;
Schara, Ulrike;
Stenzel, Werner

Publication type:

Article

Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.

Published in:

2018

By:

Kelly, Ayano;
Tong, Allison;
Tymms, Kathleen;
March, Lyn;
Craig, Jonathan C;
De Vera, Mary;
Evans, Vicki;
Hassett, Geraldine;
Toupin-April, Karine;
van den Bemt, Bart;
Teixeira-Pinto, Armando;
Alten, Rieke;
Bartlett, Susan J;
Campbell, Willemina;
Dawson, Therese;
Gill, Michael;
Hebing, Renske;
Meara, Alexa;
Nieuwlaat, Robby;
Shaw, Yomei

Publication type:

journal article

Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis.

Published in:

Expert Review of Pharmacoeconomics & Outcomes Research, 2019, v. 19, n. 5, p. 537, doi. 10.1080/14737167.2019.1647104

By:

Zrubka, Zsombor;
Gulácsi, László;
Brodszky, Valentin;
Rencz, Fanni;
Alten, Rieke;
Szekanecz, Zoltán;
Péntek, Márta

Publication type:

Article

Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis.

Published in:

2019

By:

Zrubka, Zsombor;
Gulácsi, László;
Brodszky, Valentin;
Rencz, Fanni;
Alten, Rieke;
Szekanecz, Zoltán;
Péntek, Márta

Publication type:

journal article

Physical and Emotional Burden of Rheumatoid Arthritis in Saudi Arabia: An Exploratory Cross-Sectional Study.

Published in:

Open Access Rheumatology: Research & Reviews, 2020, v. 12, p. 337, doi. 10.2147/OARRR.S284734

By:

Omair, Mohammed A;
Erdogan, Alper;
Tietz, Nicole;
Alten, Rieke

Publication type:

Article

Long-term efficacy, safety, and immunogenicity of the adalimumab biosimilar, PF-06410293, in patients with rheumatoid arthritis after switching from reference adalimumab (Humira®) or continuing biosimilar therapy: week 52–92 data from a randomized, double-blind, phase 3 trial

Published in:

Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02626-4

By:

Fleischmann, Roy M.;
Alvarez, Daniel F.;
Bock, Amy E.;
Cronenberger, Carol;
Vranic, Ivana;
Zhang, Wuyan;
Alten, Rieke

Publication type:

Article

Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials.

Published in:

Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02487-x

By:

Combe, Bernard;
Allanore, Yannick;
Alten, Rieke;
Caporali, Roberto;
Durez, Patrick;
Iannone, Florenzo;
Nurmohamed, Michael T.;
Toumi, Mondher;
Lee, Sang Joon;
Kwon, Taek Sang;
Noh, Jiwon;
Park, Gahee;
Yoo, Dae Hyun

Publication type:

Article

Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib.

Published in:

Arthritis Research & Therapy, 2020, v. 22, n. 1, p. N.PAG, doi. 10.1186/s13075-020-02324-7

By:

Strand, Vibeke;
Kaine, Jeffrey;
Alten, Rieke;
Wallenstein, Gene;
Diehl, Annette;
Shi, Harry;
Germino, Rebecca;
Murray, Christopher W.

Publication type:

Article

New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis – Implications from the prospective multicenter VADERA II study.

Published in:

PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0217412

By:

Englbrecht, Matthias;
Alten, Rieke;
Aringer, Martin;
Baerwald, Christoph G.;
Burkhardt, Harald;
Eby, Nancy;
Flacke, Jan-Paul;
Fliedner, Gerhard;
Henkemeier, Ulf;
Hofmann, Michael W.;
Kleinert, Stefan;
Kneitz, Christian;
Krüger, Klaus;
Pohl, Christoph;
Schett, Georg;
Schmalzing, Marc;
Tausche, Anne-Kathrin;
Tony, Hans-Peter;
Wendler, Jörg

Publication type:

Article

German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Published in:

Rheumatology International, 2014, v. 34, n. 1, p. 1, doi. 10.1007/s00296-013-2848-3

By:

Albrecht, Katinka;
Krüger, Klaus;
Wollenhaupt, Jürgen;
Alten, Rieke;
Backhaus, Marina;
Baerwald, Christoph;
Bolten, Wolfgang;
Braun, Jürgen;
Burkhardt, Harald;
Burmester, Gerd;
Gaubitz, Markus;
Gause, Angela;
Gromnica-Ihle, Erika;
Kellner, Herbert;
Kuipers, Jens;
Krause, Andreas;
Lorenz, Hans-Martin;
Manger, Bernhard;
Nüßlein, Hubert;
Pott, Hans-Georg

Publication type:

Article

Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology.

Published in:

Acta Neuropathologica, 2021, v. 141, n. 6, p. 917, doi. 10.1007/s00401-021-02305-3

By:

Siegert, Elise;
Uruha, Akinori;
Goebel, Hans-Hilmar;
Preuße, Corinna;
Casteleyn, Vincent;
Kleefeld, Felix;
Alten, Rieke;
Burmester, Gerd R.;
Schneider, Udo;
Höppner, Jakob;
Hahn, Kathrin;
Dittmayer, Carsten;
Stenzel, Werner

Publication type:

Article

Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or Continuing Biosimilar Therapy: Week 54–78 Data From a Randomized, Double-Blind, Phase III Trial

Published in:

BioDrugs, 2020, v. 34, n. 2, p. 197, doi. 10.1007/s40259-019-00403-z

By:

Cohen, Stanley B.;
Radominski, Sebastiao C.;
Kameda, Hideto;
Kivitz, Alan J.;
Tee, Michael;
Cronenberger, Carol;
Zhang, Min;
Hackley, Sarah;
Rehman, Muhammad I.;
von Richter, Oliver;
Alten, Rieke

Publication type:

Article

Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent.

Published in:

BioDrugs, 2018, v. 32, n. 5, p. 397, doi. 10.1007/s40259-018-0306-1

By:

Kristensen, Lars Erik;
Alten, Rieke;
Puig, Luis;
Philipp, Sandra;
Kvien, Tore K.;
Mangues, Maria Antonia;
van den Hoogen, Frank;
Pavelka, Karel;
Vulto, Arnold G.

Publication type:

Article

Factors influencing use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice.

Published in:

Patient Preference & Adherence, 2018, v. 12, p. 2007, doi. 10.2147/PPA.S170054

By:

Taylor, Peter C;
Alten, Rieke;
Reino, Juan J Gomez;
Caporali, Roberto;
Bertin, Philippe;
Sullivan, Emma;
Wood, Robert;
Piercy, James;
Vasilescu, Radu;
Spurden, Dean;
Alvir, Jose;
Tarallo, Miriam

Publication type:

Article

Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach.

Published in:

Patient Preference & Adherence, 2016, v. 10, p. 2217, doi. 10.2147/PPA.S117774

By:

Alten, Rieke;
Krüger, Klaus;
Rellecke, Julian;
Schiffner-Rohe, Julia;
Behmer, Olaf;
Schiffhorst, Guido;
Nolting, Hans-Dieter

Publication type:

Article

Predicting abatacept retention using machine learning.

Published in:

Arthritis Research & Therapy, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13075-025-03484-0

By:

Alten, Rieke;
Behar, Claire;
Merckaert, Pierre;
Afari, Ebenezer;
Vannier-Moreau, Virginie;
Ohayon, Anael;
Connolly, Sean E.;
Najm, Aurélie;
Juge, Pierre-Antoine;
Liu, Gengyuan;
Rai, Angshu;
Elbez, Yedid;
Lozenski, Karissa

Publication type:

Article

Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis – a nested case-control study within the German biologics register RABBIT.

Published in:

Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03449-9

By:

Ramien, Ronja;
Rudi, Tatjana;
Alten, Rieke;
Krause, Andreas;
Schneider, Matthias;
Schaefer, Martin;
Strangfeld, Anja;
Meissner, Yvette

Publication type:

Article

Immunogenicity of an adalimumab biosimilar, FKB327, and its reference product in patients with rheumatoid arthritis.

Published in:

International Journal of Rheumatic Diseases, 2020, v. 23, n. 11, p. 1514, doi. 10.1111/1756-185X.13951

By:

Alten, Rieke;
Markland, Colin;
Boyce, Malcolm;
Kawakami, Kazuki;
Muniz, Rafael;
Genovese, Mark C.

Publication type:

Article

Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study.

Published in:

BMC Musculoskeletal Disorders, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12891-015-0636-9

By:

Nüßlein, Hubert G.;
Alten, Rieke;
Galeazzi, Mauro;
Lorenz, Hanns-Martin;
Nurmohamed, Michael T.;
Bensen, William G.;
Burmester, Gerd R.;
Peter, Hans-Hartmut;
Pavelka, Karel;
Chartier, Melanie;
Poncet, Coralie;
Rauch, Christiane;
Le Bars, Manuela

Publication type:

Article

Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study.

Published in:

2015

By:

Nüßlein, Hubert G;
Alten, Rieke;
Galeazzi, Mauro;
Lorenz, Hanns-Martin;
Nurmohamed, Michael T;
Bensen, William G;
Burmester, Gerd R;
Peter, Hans-Hartmut;
Pavelka, Karel;
Chartier, Melanie;
Poncet, Coralie;
Rauch, Christiane;
Le Bars, Manuela

Publication type:

journal article